"Kromis, a joint venture between RDIF and the Khimrar group of companies, has signed a distribution agreement with 3Sixty Biopharmaceuticals, a subsidiary of 3Sixty Global Solutions Group, to supply the first Russian drug Avifavir for the treatment of COVID-19 in South Africa," TASS report.
In addition, in accordance with the agreement dated July 29, 2020, at least 150 thousand packages of Avifavir will be delivered to Argentina, Bolivia, Honduras, Paraguay, El Salvador, Uruguay and Ecuador.
The drug will be sold through Kromis and the Bolivian Sigma Corp SRL (Industria Quimico Farmaceutica Sigma Corp SRL).
The Bolivian company will also receive the technology for the production of the finished dosage form "Avivavira".
In mid-July, supplies of the drug "Avifavir" to Kazakhstan began.
On May 30, Avifavir received approval from the Russian Ministry of Health.